Europe – EU expands use of BioMerieux COVID-19 test

  • BioMérieux (OTC:BMXXY) announces the expansion of its ARGENE range for the detection of SARS-CoV-2. As a complement to nasopharyngeal swab specimens, the singleplex SARS-CoV-2 R-GENE real-time PCR test may now be used on saliva and oropharyngeal (throat) swab specimens, which will help optimize laboratory workflows…